Clincosm LogoSign in Get a demo

Ocular Hypertension

Showing NaN - NaN of 25
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glaucoma, Open-Angle, Ocular Hypertension Trial in Worldwide (Bimatoprost SR, Sham Bimatoprost SR, Selective Laser

Active, not recruiting
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • Bimatoprost SR
  • +3 more
  • Dothan, Alabama
  • +94 more
Nov 1, 2022

Glaucoma, Open-Angle, Ocular Hypertension Trial in United States (Test - Bimatoprost 0.01% Ophthalmic Solution, Reference -

Recruiting
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • Test - Bimatoprost 0.01% Ophthalmic Solution
  • Reference - LUMIGAN® (Bimatoprost 0.01% Ophthalmic Solution)
  • Newport Beach, California
  • +8 more
Aug 9, 2022

Open Angle Glaucoma, Ocular Hypertension Trial in United States (Brimonidine Tartrate Ophthalmic Suspension, Brimonidine

Completed
Has Results
  • Open Angle Glaucoma
  • Ocular Hypertension
  • Brimonidine Tartrate Ophthalmic Suspension
  • Brimonidine Tartrate Ophthalmic Solution
  • Chandler, Arizona
  • +46 more
Jan 27, 2022

Primary Open Angle Glaucoma, Ocular Hypertension Trial in United States (DE-126 Ophthalmic Solution 0.002% QD, Timolol Maleate

Completed
  • Primary Open Angle Glaucoma
  • Ocular Hypertension
  • DE-126 Ophthalmic Solution 0.002% QD
  • Timolol Maleate Ophthalmic Solution 0.5% BID
  • Chandler, Arizona
  • +40 more
Feb 10, 2022

Open Angle Glaucoma, Ocular Hypertension Trial in United States (Travoprost, Placebo Vehicle)

Completed
Has Results
  • Open Angle Glaucoma
  • Ocular Hypertension
  • Artesia, California
  • +9 more
Sep 14, 2021

Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (PF-04217329 - Lowest Dose, PF-04217329 - Low Dose,

Completed
Has Results
  • Primary Open-Angle Glaucoma
  • Ocular Hypertension
  • PF-04217329 - Lowest Dose
  • +8 more
  • Artesia, California
  • +22 more
Apr 6, 2021

Glaucoma, Open-Angle, Ocular Hypertension Trial in Canada, United States (Xalacom, Xalatan, Timolol)

Completed
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • Phoenix, Arizona
  • +54 more
Feb 17, 2021

Ocular Hypertension, Glaucoma Trial in United States (latanoprost 0.005%, fixed combination latanoprost-timolol, timolol 0.5%)

Completed
  • Ocular Hypertension
  • Glaucoma
  • latanoprost 0.005%
  • +2 more
  • Anaheim, California
  • +52 more
Feb 17, 2021

Ocular Hypertension, Primary Open Angle Glaucoma Trial in United States (Latanoprost ophthalmic solution, AKB-9778, Placebo)

Completed
  • Ocular Hypertension
  • Primary Open Angle Glaucoma
  • Latanoprost ophthalmic solution
  • +2 more
  • Inglewood, California
  • +20 more
Jan 13, 2021

Open Angle Glaucoma, Ocular Hypertension Trial in Worldwide (1 drop of 0.375% SYL040012 (bamosiran), 1 drop of 0.750% SYL040012

Completed
Has Results
  • Open Angle Glaucoma
  • Ocular Hypertension
  • 1 drop of 0.375% SYL040012 (bamosiran)
  • +4 more
  • Artesia, California
  • +20 more
Dec 11, 2020

Glaucoma, Ocular Hypertension Trial in United States (RKI983A, Latanoprost)

Completed
  • Glaucoma
  • Ocular Hypertension
  • Artesia, California
  • +28 more
Dec 11, 2020

Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost, Timolol 0.5%, Placebo Ocular Insert)

Completed
Has Results
  • Primary Open-Angle Glaucoma
  • Ocular Hypertension
  • Fayetteville, Arkansas
  • +9 more
May 18, 2020

Glaucoma, Open-angle, Ocular Hypertension Trial in United States (0.01% RO7058584, 0.1% RO7058584, 1% RO7058584)

Completed
  • Glaucoma, Open-angle
  • Ocular Hypertension
  • 0.01% RO7058584
  • +4 more
  • Chandler, Arizona
  • +7 more
Mar 27, 2020

Open Angle Glaucoma, Ocular Hypertension Trial in United States (Phentolamine Mesylate Ophthalmic Solution 1%, Phentolamine

Completed
  • Open Angle Glaucoma
  • Ocular Hypertension
  • Phentolamine Mesylate Ophthalmic Solution 1%
  • Phentolamine Mesylate Ophthalmic Solution Vehicle (Placebo)
  • Mission Hills, California
  • +4 more
Oct 10, 2019

Open Angle Glaucoma, Ocular Hypertension Trial in United States (PG324 Ophthalmic Solution 0.01%, PG324 Ophthalmic Solution

Completed
Has Results
  • Open Angle Glaucoma
  • Ocular Hypertension
  • PG324 Ophthalmic Solution 0.01%
  • +3 more
  • Artesia, California
  • +22 more
May 14, 2019

Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost)

Completed
Has Results
  • Primary Open-Angle Glaucoma
  • Ocular Hypertension
  • Fayetteville, Arkansas
  • +8 more
Mar 26, 2019

Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost)

Completed
Has Results
  • Primary Open-Angle Glaucoma
  • Ocular Hypertension
  • Artesia, California
  • +9 more
Feb 1, 2019

Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost, Timolol 0.5%, Placebo Eye Drops)

Completed
Has Results
  • Primary Open-Angle Glaucoma
  • Ocular Hypertension
  • Artesia, California
  • +9 more
Mar 22, 2018

Open-angle Glaucoma, Ocular Hypertension Trial in United States (DE-117 Low Dose ophthalmic solution, DE-117 Low/Middle Dose

Completed
  • Open-angle Glaucoma
  • Ocular Hypertension
  • DE-117 Low Dose ophthalmic solution
  • +5 more
  • Chandler, Arizona
  • +13 more
Apr 16, 2018

Ocular Hypertension, Open Angle Glaucoma Trial in United States (AR-13324 Ophthalmic Solution 0.01%, AR-13324 Ophthalmic

Completed
Has Results
  • Ocular Hypertension
  • Open Angle Glaucoma
  • AR-13324 Ophthalmic Solution 0.01%
  • +2 more
  • Artesia, California
  • +21 more
Mar 19, 2018

Ocular Hypertension, Open Angle-glaucoma Trial in United States (ONO-9054, Latanoprost)

Completed
  • Ocular Hypertension
  • Open Angle-glaucoma
  • Los Angeles, California
  • +11 more
Jan 26, 2016

Primary Open-angle Glaucoma, Ocular Hypertension Trial in United States (LX7101 (0.125%), LX7101 (0.25%), LX7101 Vehicle)

Completed
  • Primary Open-angle Glaucoma
  • Ocular Hypertension
  • LX7101 (0.125%)
  • +2 more
  • Morrow, Georgia
  • +4 more
Aug 31, 2015

Glaucoma, Ocular Hypertension, Eye Disease Trial in United States (AMA0076, Placebo)

Completed
  • Glaucoma
  • +2 more
  • Artesia, California
  • +8 more
Jan 16, 2015

Primary Open Angle Glaucoma, Ocular Hypertension, Elevated Intraocular Pressure Trial in Morrow (ALZ-1101, Latanoprost)

Completed
  • Primary Open Angle Glaucoma
  • +2 more
  • Morrow, Georgia
    (unnamed)
Sep 29, 2014

Open Angle Glaucoma, Ocular Hypertension Trial in United States (PG286 Ophthalmic Solution 0.5%, AR-12286 Ophthalmic Solution

Completed
  • Open Angle Glaucoma
  • Ocular Hypertension
  • PG286 Ophthalmic Solution 0.5%
  • +2 more
  • Artesia, California
  • +20 more
Feb 17, 2014